PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
145.00
-6.00 (-3.97%)
May 26, 2026, 4:04 PM WIB

IDX:LABS Cash Flow Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
12,06813,5072,9522,1902,834308.25
Depreciation & Amortization
12,15712,87912,3999,8929,2708,077
Other Operating Activities
-7,886-3,494-29,032-26,909-27,151-29,016
Operating Cash Flow
16,66422,892-13,680-14,828-15,047-20,631
Capital Expenditures
-16,684-14,210-6,809-19,405-3,280-11,710
Sale of Property, Plant & Equipment
331.02331.02392.84240.235,1471,316
Cash Acquisitions
-10.42-10.42----
Sale (Purchase) of Intangibles
-354.72-357.29-438.35-6,147--
Investment in Securities
---4,404-2,400-
Other Investing Activities
----713.06-4,511-
Investing Cash Flow
-16,718-14,247-6,855-21,621-5,044-10,394
Short-Term Debt Issued
-763.652,6512,759--
Long-Term Debt Issued
---18,86318,56333,968
Total Debt Issued
845.03763.652,65121,62218,56333,968
Long-Term Debt Repaid
--10,797-11,336-547.47-44,647-303.61
Net Debt Issued (Repaid)
-10,599-10,034-8,68521,075-26,08533,665
Issuance of Common Stock
--71,40018,16335,405-
Other Financing Activities
0--3,243---
Financing Cash Flow
-10,599-10,03459,47239,2389,32033,665
Net Cash Flow
-10,653-1,38938,9372,789-10,7702,640
Free Cash Flow
-19.698,681-20,490-34,233-18,327-32,341
Free Cash Flow Margin
-0.01%4.36%-13.88%-25.04%-19.65%-24.88%
Free Cash Flow Per Share
-0.012.20-5.19-14.54--
Cash Interest Paid
1,0911,2453,0412,1531,554112.31
Cash Income Tax Paid
15,55714,1269,7777,0664,4858,419
Levered Free Cash Flow
-2,1964,534-41,257-34,775-22,351-
Unlevered Free Cash Flow
-1,5145,313-39,357-33,430-21,380-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.